MedTrace Logo

Effects of Aging and Gender-Affirming Hormone Therapy on Vascular Endothelial Function and Metabolic Profiles in Transgender Women

NCT04066283 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 29

Last updated 2024-09-19

No results posted yet for this study

Summary

This study will examine markers of vascular endothelial function (vascular health) and metabolic profiles in younger versus older transgender women (people who were assigned male at birth but whose gender identity is female). Data will also be compared to those from cisgender women and men.

Conditions

  • Transgender
  • Gender Identity
  • Vascular Stiffness
  • Vascular Inflammation
  • Insulin Sensitivity
  • Blood Pressure
  • Lipid Disorder
  • Appetitive Behavior

Interventions

OTHER

No intervention

There was no intervention in this study

Sponsors & Collaborators

  • National Center for Advancing Translational Sciences (NCATS)

    collaborator NIH

  • University of Colorado, Denver

    lead OTHER

Principal Investigators

  • Sean Iwamoto, MD · University of Colorado, Denver

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-04-17
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04066283 on ClinicalTrials.gov